BrightInsight key facts
as of Oct 2026- Developer of a digital health platform designed to optimize regulated drugs, devices, and software through integrated data and actionable insight.
- BrightInsight is valued at approximately $750.0M as of Oct 2026, set at its later-stage round, Mar 2021; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $224.9M across 3 recorded rounds; the latest was Later Stage VC ($101.0M) in Mar 2021.
- Notable investors include General Catalyst, Insight Partners (New York), Gaingels, OurCrowd, Sand Hill Angels — 13 tracked in total.
- BrightInsight has filed 3 Form Ds with the SEC since 2019, most recently May 2021 ($101.0M sold to 22 investors).
- Status: Privately Held (backing).
Valued at $750.0M at its later-stage round, Mar 2021. Nothing has traded since.
- ·The complete investor list: 13 names
- ·Watch BrightInsight: the Monday email on marks, rounds and moves
BrightInsight funding rounds
3 roundsWho backs BrightInsight
13+BrightInsight valuation
BrightInsight was valued at $750 million at its later-stage round in Mar 2021. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has BrightInsight raised?
BrightInsight has raised $225 million across 3 recorded rounds since 2019. The largest was a $40.1 million early-stage round in Jun 2020; the most recent was a $101 million later-stage round in Mar 2021.
BrightInsight has filed 3 Form Ds with the SEC since 2019, most recently in May 2021 ($101 million sold to 22 investors).
BrightInsight investors
13 investors are on record for BrightInsight, including General Catalyst, Insight Partners (New York), Gaingels and OurCrowd. By type, the record holds 7 venture capital firms, 1 family office and 1 hedge fund. The later-stage round in Mar 2021 drew 22 investors.
About BrightInsight
Developer of a digital health platform designed to optimize regulated drugs, devices, and software through integrated data and actionable insight. The company's platform uses software and services to capture, transmit, and analyze data from CE-marked and FDA-regulated medical devices, combination products, applications and software as a medical device, in compliance with security, privacy, and regulatory requirements, enabling biopharma and med-tech companies to accelerate their time to market, reduce the cost of implementation and scaling across products and global markets.
- Sector
- Healthcare
- HQ
- San Jose, CA, United States
- Founded
- 2017
- Employees
- 163
- Website
- brightinsight.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.